Nurofen Cold & Flu PE

Quick links

Choose a section

Quick links to important sections

Advertisements

Nurofen Cold & Flu PE

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Nurofen Cold & Flu PE

Property Description
Active Ingredients Ibuprofen, Phenylephrine Hydrochloride
Form Fixed-combination tablet or capsule
Pharmacological Class NSAID and Sympathomimetic combination
Common Use Symptomatic relief of cold and flu
Origin Synthetic chemical compounds

Defining Nurofen Cold & Flu PE: Combination and Classification

Nurofen Cold & Flu PE is a synthetic, fixed-combination medicinal product taken orally, combining two agents from distinct pharmacological classes to manage multiple cold symptoms simultaneously. The preparation is commonly supplied as an Over-The-Counter (OTC) medicine, often in the form of a film-coated tablet or capsule, for administration via the oral route. Its composition includes Ibuprofen, which is classified as an NSAID, and Phenylephrine Hydrochloride, which is an alpha1-Adrenergic Receptor Agonist and a sympathomimetic agent. The formulation is often clinically recognized for its efficiency in addressing co-occurring symptoms of upper respiratory infections.


Core Components and Dual-Action Purpose

The medicine utilizes the active ingredients Ibuprofen and Phenylephrine Hydrochloride to target both pain/fever pathways and nasal congestion in one preparation. The Ibuprofen component provides systemic pain and fever modulation and is recognized for its analgesic and antipyretic effects. The second component, Phenylephrine Hydrochloride, functions specifically as a nasal decongestant, working to reduce swelling in the nasal passages; this helps clear a stuffy nose by shrinking blood vessels in the sinuses. The therapeutic use of this compound product is the temporary, symptomatic relief of general discomforts, such as aches and pains and fever, concurrently with localized issues like blocked nose and sinus pressure associated with the common cold or flu.


How is Nurofen Cold & Flu PE Different from Single-Ingredient Relief?

This preparation offers a comprehensive approach by delivering both anti-inflammatory action and targeted vascular constriction in a single oral dose, unlike medications that address only one symptom. The inclusion of Phenylephrine Hydrochloride provides a specific, direct means of reducing oedema and nasal swelling in the upper airways. This integrated formulation enables patients to secure relief for both the constitutional symptoms and the physical difficulty of nasal blockage via one method of oral administration, avoiding the need to combine multiple single-agent medicines.

Advertisements

What side effects are possible with Nurofen Cold & Flu PE?

The official safety documentation for this combination medicine classifies potential adverse reactions based on the physiological system affected and the documented frequency of occurrence.

Officially Documented Adverse Reaction Scope

Adverse reaction scope Details
Key adverse reaction categories Gastrointestinal disturbances, Nervous System effects, Immune System and Severe Cutaneous Adverse Reactions (SCARs), and Cardiovascular events.
Frequency classification Uncommon effects (e.g., Nausea, Dyspepsia, Headache, Skin Rashes) and Rare effects (e.g., Vomiting, Diarrhoea) are listed. Very Rare events include serious complications like Gastrointestinal Haemorrhage/Perforation and Aseptic Meningitis.
System-organ classes involved Reactions are organized into Gastrointestinal Disorders, Nervous System Disorders, Immune System Disorders, and Cardiac/Vascular Disorders.
Serious adverse reactions Regulatory labels contain warnings regarding the potential for Serious Cardiovascular Thrombotic Events (e.g., Myocardial Infarction and Stroke) and severe Gastrointestinal Adverse Events (bleeding, ulceration, or perforation). Severe hypersensitivity reactions are also documented.
Population-specific safety considerations The elderly population is noted to have a higher risk for serious gastrointestinal adverse events. Use of the NSAID component may potentially impair female fertility, an effect generally reversible upon discontinuation.
Dose- or exposure-related patterns An increased risk of arterial thrombotic events is officially associated with high doses and prolonged use. Serious skin reactions are documented to occur most often within the first month of treatment.

Connection to the Official Safety Profile

This structure establishes the regulatory risk classification by separating common, non-serious side effects from rare, critical events, ensuring the full spectrum of officially defined safety characteristics is communicated. The safety information includes mandatory warnings related to major system risks and defines constraints for specific at-risk populations.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory labeling strictly documents the recognized clinical manifestations and required emergency actions associated with an overdose of Ibuprofen and Phenylephrine Hydrochloride.

Overdose presentations include a range of symptoms from both components. Ibuprofen toxicity may present with gastrointestinal distress, such as nausea, vomiting, and epigastric pain, as well as CNS effects like drowsiness, disorientation, and tinnitus (ringing in the ears). Phenylephrine toxicity can lead to sympathomimetic effects including tachycardia (rapid heart rate) and increased blood pressure.

Severe outcomes documented in official sources, particularly involving the CNS and renal systems, include life-threatening events such as seizures, coma, metabolic acidosis, and acute renal failure. The elderly population is noted to have a higher risk of severe gastrointestinal effects.

Required Emergency Action

If overdose is suspected, official regulatory instructions mandate that immediate medical assistance must be sought. Specifically, get medical help or contact a Poison Control Center right away. Urgent attention is required if severe symptoms like sudden severe headache, confusion, seizures, or visual disturbances are observed.

Management is described as symptomatic and supportive, as no specific pharmacological antidote is documented in the labeling. This supportive approach includes monitoring of cardiac and vital signs and may involve procedures like the use of activated charcoal if the person presents within one hour of ingestion.

Advertisements

Therapeutic Uses of Nurofen Cold & Flu PE

What Nurofen Cold & Flu PE Treats: Main Uses and Benefits

This combination preparation is generally applied across conditions presenting with acute, simultaneous manifestations of cold or flu-like symptoms. It is used to provide supportive symptomatic relief across key domains, including fever, body aches, headache, and nasal congestion. It is relevant when symptoms create noticeable physiological strain and interference with daily comfort.

The medication is commonly used when short-term symptomatic assistance is needed to manage both systemic discomfort and localized respiratory symptoms. Specifically, it plays a role in managing generalized aches, muscle pain, and joint discomfort, while generally assisting in managing symptoms related to elevated body temperature (fever). It is also relevant for easing symptoms related to nasal congestion and sinus pressure. This dual approach helps address symptom clusters that may become intense or disruptive.

“This symptomatic support helps ease the overall symptom burden and assists with maintaining functional stability during difficult episodes.”


Quick Fact: Relief for Co-occurring Symptoms

This medication is applied in scenarios where multiple cold or flu symptoms occur together. It is applied in situations where symptoms create noticeable physiological strain, supporting relief for both generalized discomfort and nasal obstruction.

Regulatory References

  1. NIH DailyMed label
Advertisements

Eligibility and Restrictions for Use

The official regulatory profile for Nurofen Cold & Flu PE defines eligibility based on age, pre-existing health status, and hypersensitivity. The medicine is approved for use in adults and adolescents aged 12 years and over. Use is contraindicated in children under 12 years of age because the fixed-combination dose contains too much medication for this age group.

Contraindications

Absolute non-eligibility is stated for patients with severe coronary heart disease or uncontrolled hypertension, severe heart failure (NYHA Class IV), and those taking or who have taken a Monoamine Oxidase Inhibitor (MAOI) within the last 14 days. The medicine is also prohibited for individuals with active or history of recurrent peptic ulcer/haemorrhage, severe renal failure, severe hepatic failure, or known hypersensitivity to ibuprofen, aspirin, or other NSAIDs.

Restricted Use

Use is contraindicated during the last trimester of pregnancy (from 20-30 weeks gestation) and is not recommended for use while breastfeeding. Caution is required for the elderly due to an increased risk of gastrointestinal bleeding, and for patients with conditions such as moderate organ impairment, diabetes, asthma, or prostatic enlargement.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This combination medicine has formally documented interaction patterns arising from its two active components, Ibuprofen and Phenylephrine Hydrochloride. Contraindicated combinations strictly prohibit co-administration with Monoamine Oxidase Inhibitors ( MAOIs) and require a mandatory 14-day separation after discontinuing MAOI therapy. Use is also prohibited with other Non-Steroidal Anti-Inflammatory Drugs ( NSAIDs), COX-2 inhibitors, and Ergot Alkaloids. The medicine is contraindicated immediately before or after Coronary Artery Bypass Grafting ( CABG) surgery.

Pharmacodynamic Interactions include an increased risk of gastrointestinal bleeding when co-administered with anticoagulants (such as Warfarin), corticosteroids, or selective serotonin reuptake inhibitors ( SSRIs). The Ibuprofen component may reduce the antiplatelet effect of low-dose aspirin and can diminish the therapeutic efficacy of anti-hypertensive medicines, including ACE inhibitors and diuretics. The Phenylephrine component carries a risk of additive sympathetic effects when combined with other decongestants.

Exposure-Modifying Interactions involve Ibuprofen decreasing the renal clearance of substances like Lithium and Methotrexate, leading to an officially documented increase in their plasma concentrations. The regulatory information also notes that alcohol consumption increases the risk of stomach bleeding, and the risk of severe bleeding is higher in individuals age 60 or older when co-administered with other interacting medicines.

Advertisements

Mechanism of Action

Enzymatic Suppression of Systemic Prostaglandin Signaling

The Ibuprofen component acts within the domain of eicosanoid signaling by functioning as a reversible inhibitor of Cyclooxygenase (COX) enzymes. This targeted inhibition restricts the synthesis of prostaglandins (PGs) both in the periphery and centrally within the hypothalamus. This action restricts the PG-mediated sensitization of peripheral nociceptors and contributes to a decrease in the hypothalamic thermoregulatory set point.


Localized alpha1 -Adrenergic Vasoconstriction

The Phenylephrine component engages the sympathetic autonomic nervous system by acting as a direct-acting agonist on alpha1 -adrenergic receptors found on the vascular smooth muscle lining of the nasal and sinus mucosa. This activation initiates vasoconstriction, leading to a localized physical reduction in blood flow and tissue volume. This mechanism alters the vascular dynamics within the nasal mucosa, leading to a physical decrease in interstitial fluid accumulation and tissue volume.

Advertisements

Dosage and Administration Information

The use of Nurofen Cold & Flu PE is governed by explicit instructions detailing the administration route, dosing limits, frequency, and duration. This fixed-combination product, containing Ibuprofen 200 mg and Phenylephrine 5 mg per unit, is intended for oral administration. The tablets must be swallowed whole with water, and instructions specify that the tablets should not be chewed.

Official Dosing and Frequency

The administration pattern is specified.

Dosing Parameter Official Label Requirement
Initial Dose (Adults/12+ years) Two tablets (400 mg Ibuprofen / 10 mg Phenylephrine)
Subsequent Dose One or two tablets as required
Minimum Interval Four hours between doses
Maximum Daily Limit Six tablets (1200 mg Ibuprofen / 30 mg Phenylephrine) in 24 hours

Procedural and Population Constraints

The medication is intended for use in adults and adolescents aged 12 years and older, and its administration is prohibited in children below this age. The entire course of therapy is designated for short-term use only, and this limitation must be observed before seeking additional professional guidance. All dosing must conform to the requirement of taking the lowest effective dose for the shortest duration necessary to achieve the desired effect. This framework establishes a precise, controlled protocol for the use of the combination medicine.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Nurofen Cold & Flu PE


Evidence for Constitutional Symptoms: Pain and Fever Relief

Research exploring the NSAID component was conducted in studies examining outcomes related to fever and physical discomfort. This research primarily relies on Randomized Controlled Trials (RCTs), which are used in research exploring how symptoms change over time and are considered relevant in trials assessing short-term or episodic symptom patterns. Studies monitored axes related to systemic or functional imbalance, including patient-reported outcomes describing perceived discomfort, such as headache and body ache severity.

Trials applied in studies examining patient-reported experiences explored changes in body temperature when the analgesic component was administered to subjects presenting with fever. Research describes patterns related to changes measured during the study period for reported pain scores for symptoms like headache and muscle aches. Findings describe patterns observed in the studies that typically focus on the acute period, with symptom assessments measured within the first several hours following administration.


Evidence for Localized Symptoms: Nasal Decongestion

Research exploring the decongestant component (Phenylephrine) focused on studies evaluating acute cold symptoms. Studies often examined outcomes linked to inflammatory or irritative states, such as patient ratings of nasal stuffiness and obstruction. Studies were observed in research settings with varying symptom burdens and generally included adults experiencing nasal congestion associated with acute or disruptive episodes.

Research Consistency for Oral Decongestants

Specific regulatory bodies have described evidence heterogeneity regarding the clinical significance of the oral decongestant component at approved over-the-counter dosages. Findings related to the decongestant were observed in some studies to be mixed. Certainty remains low regarding the effectiveness of the oral decongestant component at common doses, and data show patterns related to limited and inconsistent findings across different research efforts.


Evidence Gaps and Areas of Uncertainty

Follow-up durations were limited across the majority of the existing research, meaning that long-term effects of this combination are not fully established. Data for certain groups, such as older adults or individuals with specific underlying chronic conditions, remain insufficient. Research highlights what is known—and what is still uncertain—but the existing studies provide limited insight into comparative research on this combination.

Key Studies & References NIH DailyMed Label for Ibuprofen and Phenylephrine combination products

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Nurofen Cold & Flu PE (FAQ)


Q: How quickly do the effects of Nurofen Cold & Flu PE typically begin to be noticed?

Regulatory information indicates that the Ibuprofen component is absorbed relatively quickly. While the exact time may vary for the combination product, based on the dosing schedule, relief is typically sought and measured within a few hours following administration.


Q: How long can the relief from one dose of Nurofen Cold & Flu PE be expected to last?

Official administration documents establish a minimum interval of four hours between doses. This minimum time interval is established in the regulatory documentation for determining subsequent doses.


Q: Is Nurofen Cold & Flu PE known to cause difficulty sleeping or insomnia?

Official product information lists difficulty sleeping (insomnia) as a possible undesirable effect. Other central nervous system effects such as restlessness and nervousness have also been reported.


Q: Can Nurofen Cold & Flu PE be taken alongside other pain relievers like paracetamol (acetaminophen)?

Regulatory guidance suggests that paracetamol (acetaminophen) is generally not listed as a contraindication with the ibuprofen component. However, combining this product with other cold or flu medicines that contain a decongestant requires careful consideration due to the risk of additive effects.


Q: What do studies say about the time it takes for the decongestant part of the medicine to work?

Regulatory reviews of the decongestant component, Phenylephrine, acknowledge that the time it takes to reach maximum concentration may vary. However, the product's characteristics are considered adequate for the intended temporary relief of acute cold and flu symptoms.


Q: Why are people over 65 years old often advised to consult a healthcare professional before taking this drug?

Official documents contain a specific warning regarding the elderly population. This is because older adults are noted to have a higher risk for serious side effects, particularly gastrointestinal bleeding, which is associated with the Ibuprofen component.


Q: Is Nurofen Cold & Flu PE considered a medicine for managing pain in general, or only for cold/flu-related pain?

This medication is specifically indicated for the temporary symptomatic relief of symptoms associated with colds and sinusitis. This includes managing aches, pains, and fever that occur alongside nasal congestion.


Q: Is the decongestant component in this medicine the same as in other brands?

The decongestant component used in this product is Phenylephrine Hydrochloride. While this ingredient is common, other brands of cold and flu medicine may use different decongestants, or none at all.


Q: Is Nurofen Cold & Flu PE known to cause drowsiness?

Official information frequently describes this product as offering non-drowsy relief. However, some central nervous system side effects have been reported, such as dizziness or headache.


Q: Is it common to experience dry mouth or nervousness while taking this product?

Official product information lists both nervousness and dry mouth/sore mouth among the possible adverse effects that users may experience.


Q: Are there any specific food or beverage groups mentioned in official warnings for Nurofen Cold & Flu PE?

The primary interaction warning related to consumption involves alcohol. Official warnings state that drinking alcohol can increase the risk of stomach bleeding associated with the ibuprofen component.


Q: What are the signs of gastrointestinal bleeding that users should be aware of?

Warnings in official safety documentation mention serious signs that require attention. These include vomiting blood, having bloody or dark, tarry stools, and experiencing severe or persistent stomach pain.


Q: Is there any information about Nurofen Cold & Flu PE causing sensitivity to sunlight?

Official product documentation includes a potential skin reaction known as photosensitivity, which means the skin may become more sensitive to sunlight while using the product.


Q: What is the recommended storage temperature and condition for Nurofen Cold & Flu PE tablets?

Regulatory documents require that the medicine be stored at a controlled room temperature, specifically below 25^circC (77^circF). It must also be kept in its original packaging to ensure protection from moisture.


Q: Why do some people experience restlessness or agitation after taking combination cold and flu medicines?

The decongestant component is classified as a sympathomimetic agent, which means it affects the sympathetic nervous system. Official documents list restlessness and agitation as possible undesirable effects resulting from this action.


Q: Does Nurofen Cold & Flu PE contain any ingredients that are known to cause allergic reactions besides the active components?

Official documentation lists the full contents, including non-active excipients (fillers, coatings, etc.). Contraindications include known allergy to any ingredient listed in the product information.


Q: Is there an official statement regarding the safety of Nurofen Cold & Flu PE for pregnant or breastfeeding women?

Official safety documents state that the medicine is contraindicated (prohibited) during the last trimester of pregnancy (after 20-30 weeks gestation). It is also not recommended for use while breastfeeding.


Q: What are the reported symptoms of taking more Nurofen Cold & Flu PE than the recommended amount?

In cases of exceeding the recommended use, regulatory documents report symptoms that may include nausea, vomiting, headache, blurred vision, anxiety, and drowsiness. Severe symptoms may involve more serious issues like stomach bleeding.


Q: How does the PE component, Phenylephrine, specifically help with a blocked nose and sinuses?

Phenylephrine works as a nasal decongestant by causing the blood vessels in the nasal and sinus lining to constrict (narrow). This action reduces blood flow and swelling, which helps to relieve the feeling of a blocked or stuffy nose.


Q: Can Nurofen Cold & Flu PE be used for a sore throat that is not accompanied by a blocked nose?

The medicine is officially indicated for the combined relief of symptoms, including pain, fever, and nasal congestion. It is not generally intended for use only when congestion is absent.


Q: Is there a known effect of this drug on eye pressure or conditions like glaucoma?

Official warnings list glaucoma as a condition that requires caution or contraindication, especially narrow-angle glaucoma. This is due to the potential effects of the decongestant component on eye pressure.


Q: What are the warnings related to using Nurofen Cold & Flu PE with a pre-existing thyroid condition?

Official safety warnings indicate that individuals with an overactive thyroid gland (hyperthyroidism) should exercise caution when using this medicine.


Q: Does taking Nurofen Cold & Flu PE generally make a person feel more anxious?

Official documentation lists anxiety as a possible side effect associated with the use of the medicine.


Q: Are there any specific official recommendations about taking this medication with or without food?

Regulatory guidance suggests that if a person has a sensitive stomach, the product can be taken during a meal.


Q: Is there a risk of developing skin rashes like Stevens-Johnson Syndrome with this drug?

Official safety documents warn about rare but serious skin reactions known as Severe Cutaneous Adverse Reactions (SCARs), explicitly including Stevens-Johnson Syndrome (SJS). Regulatory documents describe discontinuation of use at the first sign of rash.

Advertisements

How should Nurofen Cold & Flu PE be stored and disposed of?

Official Storage and Disposal Requirements

Nurofen Cold & Flu PE must be stored and handled according to specific regulatory parameters to ensure the stability of its active ingredients, Ibuprofen and Phenylephrine.

Storage Conditions

  • Temperature: Store at controlled room temperature, typically below 25°C (77°F), and avoid exposure to excessive heat above 40°C (104°F).
  • Protection: The product must be kept in the original package to protect it from moisture. Do not use the medicine after the expiry date printed on the carton.
  • Child Safety: It is a mandatory requirement to keep the medicine out of sight and reach of children.

Disposal Instructions

  • Safe Disposal: Expired, damaged, or unused Nurofen Cold & Flu PE must be returned to a pharmacist for safe disposal.

These guidelines prevent product degradation and ensure proper pharmaceutical waste management.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nurofen Cold & Flu PE found in:

A-Z Index: